Effect of daunorubicin on acute promyelocytic leukemia cells using nuclear magnetic resonance spectroscopy-based metabolomics
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 78, 103382
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 33 references indexed in Scilit:
- Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemiaBlood, 2017
- Emerging New Strategies for Successful Metabolite Identification in MetabolomicsBioanalysis, 2016
- Targeting Agents Alone to Cure Acute Promyelocytic LeukemiaNew England Journal of Medicine, 2013
- High-Throughput Omics Technologies: Potential Tools for the Investigation of Influences of EMF on Biological SystemsCurrent Genomics, 2009
- Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS)Journal of Proteome Research, 2008
- Metabolic Fingerprinting As A Diagnostic ToolPharmacogenomics, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Induction of Differentiation and Apoptosis— A Possible Strategy in the Treatment of Adult Acute Myelogenous LeukemiaThe Oncologist, 2000
- Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapyBlood, 1984
- Acute Promyelocytic LeukemiaArchives of internal medicine (1960), 1978